ACH
INBX

ArrowMark Colorado Holdings’s Inhibrx, Inc. Common Stock INBX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-891,220
Closed -$31.2M – 333
2024
Q1 		$31.2M Sell
891,220
-65,661
-7% -$2.39M 0.35% 78
2023
Q4 		$36.4M Sell
956,881
-9,115
-0.9% -$195K 0.4% 70
2023
Q3 		$17.7M Buy
965,996
+7,116
+0.7% +$149K 0.22% 102
2023
Q2 		$24.9M Buy
958,880
+17,457
+2% +$408K 0.27% 88
2023
Q1 		$17.8M Sell
941,423
-197,914
-17% -$4.6M 0.2% 101
2022
Q4 		$28.1M Sell
1,139,337
-199,690
-15% -$5.87M 0.34% 84
2022
Q3 		$24M Sell
1,339,027
-73,209
-5% -$1.32M 0.29% 91
2022
Q2 		$16M Buy
1,412,236
+122,763
+10% +$1.81M 0.18% 119
2022
Q1 		$28.7M Buy
1,289,473
+21,713
+2% +$554K 0.25% 101
2021
Q4 		$55.4M Sell
1,267,760
-117,882
-9% -$4.71M 0.44% 71
2021
Q3 		$46.2M Sell
1,385,642
-59,188
-4% -$1.8M 0.36% 80
2021
Q2 		$39.8M Sell
1,444,830
-87,957
-6% -$1.83M 0.3% 93
2021
Q1 		$30.8M Sell
1,532,787
-23,532
-2% -$687K 0.23% 101
2020
Q4 		$51.3M Buy
1,556,319
+1,056,593
+211% +$28.1M 0.4% 75
2020
Q3 		$8.99M Buy
+499,726
New +$9.06M 0.09% 161

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

ArrowMark Colorado Holdings's INBX Position: Q2 2024 in Review

ArrowMark Colorado Holdings sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 891,220 shares — an estimated $31.2M sold.

ArrowMark Colorado Holdings first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $55.4M in Q4 2021. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • ArrowMark Colorado Holdings reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 891,220 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $31.2M.
  • ArrowMark Colorado Holdings first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • ArrowMark Colorado Holdings's Inhibrx, Inc. Common Stock position peaked at $55.4M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2024, filed 14 Aug 2024.